Europe Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Pain Management Devices Market
The Europe Pain Management Devices Market would witness market growth of 8.1% CAGR during the forecast period (2020-2026). The key products used to treat various degrees of pain are electrical stimulators, radiofrequency ablation (RFA), analgesic infusion, and neuromodulation & neurostimulation devices. The market, in 2019 was led by the segment of neuromodulation & neurostimulation devices, which includes spinal cord stimulators (SCS), deep brain stimulators (DBS), and sacral neurostimulators.
These devices have wide-ranging uses in chronic pain management, including spinal cord stimulation, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and electric respiratory stimulation. Neurostimulation devices are more efficient than traditional methods because they show sustained pain reduction. Additionally, traditional therapy requires the intake of medicinal products which may have many adverse effects. Those factors are expected to contribute to this segment 's growth.
Radiofrequency ablation devices played a major role in the treatment of cancer pain. These devices exert action through high-temperature thermal therapy, which by heating tissue to 100ºC induces the coagulation of necrotic cells. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Europe Pain Management Devices Market Analysis
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
- Rest of Europe
- Abbott Laboratories
- Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free